{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T10:26:36Z","timestamp":1743157596173,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493997473"},{"type":"electronic","value":"9781493997480"}],"license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-4939-9748-0_17","type":"book-chapter","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T16:02:53Z","timestamp":1566835373000},"page":"303-317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["High-Content Screening for Cryptosporidium Drug Discovery"],"prefix":"10.1007","author":[{"given":"Melissa S.","family":"Love","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Case W.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"issue":"9888","key":"17_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","volume":"382","author":"KL Kotloff","year":"2013","unstructured":"Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acacio S, Biswas K, O\u2019Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM (2013) Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382(9888):209\u2013222. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(13)60844-2","journal-title":"Lancet"},{"issue":"9","key":"17_CR2","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1016\/s2214-109x(15)00151-5","volume":"3","author":"JA Platts-Mills","year":"2015","unstructured":"Platts-Mills JA, Babji S, Bodhidatta L, Gratz J, Haque R, Havt A, McCormick BJ, McGrath M, Olortegui MP, Samie A, Shakoor S, Mondal D, Lima IF, Hariraju D, Rayamajhi BB, Qureshi S, Kabir F, Yori PP, Mufamadi B, Amour C, Carreon JD, Richard SA, Lang D, Bessong P, Mduma E, Ahmed T, Lima AA, Mason CJ, Zaidi AK, Bhutta ZA, Kosek M, Guerrant RL, Gottlieb M, Miller M, Kang G, Houpt ER (2015) Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health 3(9):e564\u2013e575. \nhttps:\/\/doi.org\/10.1016\/s2214-109x(15)00151-5","journal-title":"Lancet Glob Health"},{"issue":"3","key":"17_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1128\/CMR.15.3.390-400.2002","volume":"15","author":"MJ Arrowood","year":"2002","unstructured":"Arrowood MJ (2002) In vitro cultivation of Cryptosporidium species. Clin Microbiol Rev 15(3):390\u2013400","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"17_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0020-7519(01)00212-0","volume":"31","author":"NS Hijjawi","year":"2001","unstructured":"Hijjawi NS, Meloni BP, Morgan UM, Thompson RC (2001) Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture. Int J Parasitol 31(10):1048\u20131055","journal-title":"Int J Parasitol"},{"issue":"1\u20132","key":"17_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1574-6968.1994.tb06801.x","volume":"118","author":"SJ Upton","year":"1994","unstructured":"Upton SJ, Tilley M, Nesterenko MV, Brillhart DB (1994) A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiol Lett 118(1\u20132):45\u201349","journal-title":"FEMS Microbiol Lett"},{"issue":"4","key":"17_CR6","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1128\/aac.02460-12","volume":"57","author":"K Bessoff","year":"2013","unstructured":"Bessoff K, Sateriale A, Lee KK, Huston CD (2013) Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth. Antimicrob Agents Chemother 57(4):1804\u20131814. \nhttps:\/\/doi.org\/10.1128\/aac.02460-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"17_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1021\/ml100096t","volume":"1","author":"RC Murphy","year":"2010","unstructured":"Murphy RC, Ojo KK, Larson ET, Castellanos-Gonzalez A, Perera BG, Keyloun KR, Kim JE, Bhandari JG, Muller NR, Verlinde CL, White AC Jr, Merritt EA, Van Voorhis WC, Maly DJ (2010) Discovery of potent and selective inhibitors of calcium-dependent protein kinase 1 (CDPK1) from C. parvum and T. gondii. ACS Med Chem Lett 1(7):331\u2013335. \nhttps:\/\/doi.org\/10.1021\/ml100096t","journal-title":"ACS Med Chem Lett"},{"issue":"8","key":"17_CR8","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1371\/journal.pntd.0000794","volume":"4","author":"L Sharling","year":"2010","unstructured":"Sharling L, Liu X, Gollapalli DR, Maurya SK, Hedstrom L, Striepen B (2010) A screening pipeline for antiparasitic agents targeting Cryptosporidium inosine monophosphate dehydrogenase. PLoS Negl Trop Dis 4(8):e794. \nhttps:\/\/doi.org\/10.1371\/journal.pntd.0000794","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"17_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.chembiol.2007.12.010","volume":"15","author":"NN Umejiego","year":"2008","unstructured":"Umejiego NN, Gollapalli D, Sharling L, Volftsun A, Lu J, Benjamin NN, Stroupe AH, Riera TV, Striepen B, Hedstrom L (2008) Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis. Chem Biol 15(1):70\u201377. \nhttps:\/\/doi.org\/10.1016\/j.chembiol.2007.12.010","journal-title":"Chem Biol"},{"issue":"3","key":"17_CR10","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1128\/aac.02075-13","volume":"58","author":"SK Gorla","year":"2014","unstructured":"Gorla SK, McNair NN, Yang G, Gao S, Hu M, Jala VR, Haribabu B, Striepen B, Cuny GD, Mead JR, Hedstrom L (2014) Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis. Antimicrob Agents Chemother 58(3):1603\u20131614. \nhttps:\/\/doi.org\/10.1128\/aac.02075-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"17_CR11","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1128\/aac.02641-13","volume":"58","author":"K Bessoff","year":"2014","unstructured":"Bessoff K, Spangenberg T, Foderaro JE, Jumani RS, Ward GE, Huston CD (2014) Identification of Cryptosporidium parvum active chemical series by repurposing the open access malaria box. Antimicrob Agents Chemother 58(5):2731\u20132739. \nhttps:\/\/doi.org\/10.1128\/aac.02641-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"7658","key":"17_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature22337","volume":"546","author":"UH Manjunatha","year":"2017","unstructured":"Manjunatha UH, Vinayak S, Zambriski JA, Chao AT, Sy T, Noble CG, Bonamy GMC, Kondreddi RR, Zou B, Gedeck P, Brooks CF, Herbert GT, Sateriale A, Tandel J, Noh S, Lakshminarayana SB, Lim SH, Goodman LB, Bodenreider C, Feng G, Zhang L, Blasco F, Wagner J, Leong FJ, Striepen B, Diagana TT (2017) A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis. Nature 546(7658):376\u2013380. \nhttps:\/\/doi.org\/10.1038\/nature22337","journal-title":"Nature"},{"issue":"4","key":"17_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1021\/acs.jnatprod.7b00850","volume":"81","author":"JJ Chen","year":"2018","unstructured":"Chen JJ, Rateb ME, Love MS, Xu Z, Yang D, Zhu X, Huang Y, Zhao LX, Jiang Y, Duan Y, McNamara CW, Shen B (2018) Herbicidins from Streptomyces sp. CB01388 showing anti-Cryptosporidium activity. J Nat Prod 81(4):791\u2013797. \nhttps:\/\/doi.org\/10.1021\/acs.jnatprod.7b00850","journal-title":"J Nat Prod"},{"issue":"2","key":"17_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005373","volume":"11","author":"MS Love","year":"2017","unstructured":"Love MS, Beasley FC, Jumani RS, Wright TM, Chatterjee AK, Huston CD, Schultz PG, McNamara CW (2017) A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. PLoS Negl Trop Dis 11(2):e0005373. \nhttps:\/\/doi.org\/10.1371\/journal.pntd.0005373","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"17_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1089\/154065803322302826","volume":"1","author":"KA Giuliano","year":"2003","unstructured":"Giuliano KA, Haskins JR, Taylor DL (2003) Advances in high content screening for drug discovery. Assay Drug Dev Technol 1(4):565\u2013577. \nhttps:\/\/doi.org\/10.1089\/154065803322302826","journal-title":"Assay Drug Dev Technol"},{"issue":"8","key":"17_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/cyto.a.22885","volume":"89","author":"ML Ang","year":"2016","unstructured":"Ang ML, Pethe K (2016) Contribution of high-content imaging technologies to the development of anti-infective drugs. Cytometry A 89(8):755\u2013760. \nhttps:\/\/doi.org\/10.1002\/cyto.a.22885","journal-title":"Cytometry A"},{"issue":"2","key":"17_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67\u201373. \nhttps:\/\/doi.org\/10.1177\/108705719900400206","journal-title":"J Biomol Screen"}],"container-title":["Methods in Molecular Biology","Cryptosporidium"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9748-0_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T18:05:19Z","timestamp":1583172319000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9748-0_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"ISBN":["9781493997473","9781493997480"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9748-0_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"27 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}